Mark Dransfield

Title: Mark Dransfield: Innovator in Mucociliary Clearance

Introduction

Mark Dransfield is an accomplished inventor based in Homewood, Alabama. He has made significant contributions to the field of medical research, particularly in the area of mucociliary clearance. His innovative work has the potential to improve the quality of life for individuals with respiratory conditions.

Latest Patents

Mark Dransfield holds a patent for "Methods for increasing CFTR activity." This patent describes compounds that are effective in enhancing mucociliary clearance in subjects. The compounds are designed to increase the activation of the CFTR, which in turn improves mucociliary clearance. Additionally, the compounds are shown to increase the depth of airway surface liquid (ASL), further aiding in mucociliary clearance. Importantly, the patent specifies that the subject should be free from congenital or genetic defects in the cellular mucociliary clearance apparatus.

Career Highlights

Dransfield is associated with the UAB Research Foundation, where he continues to advance his research and innovation. His work is characterized by a commitment to developing effective solutions for respiratory health challenges. With a focus on practical applications, he aims to translate his research into real-world benefits for patients.

Collaborations

Mark Dransfield has collaborated with Steven Mark Rowe, a fellow researcher in the field. Their partnership has contributed to the advancement of knowledge and innovation in mucociliary clearance.

Conclusion

Mark Dransfield's contributions to the field of mucociliary clearance through his patent and research at the UAB Research Foundation highlight his dedication to improving respiratory health. His innovative approaches have the potential to make a significant impact on patient care.